Article(id=1329905806335652212, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905755949478607, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2025.08.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1729180800000, receivedDateStr=2024-10-18, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795003852684, onlineDateStr=2026-11-18, pubDate=1754755200000, pubDateStr=2025-08-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795003852684, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795003852684, creator=13701087609, updateTime=1795003852684, updator=13701087609, issue=Issue{id=1329905755949478607, tenantId=1146029695717560320, journalId=1319690259887390882, year='2025', volume='56', issue='8', pageStart='975', pageEnd='1108', issueExtLink='null', onlineDate='null', pubDate='1754755200000', pubDateStr='2025-08-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=0, createTime=1795003840672, creator='13701087609', updateTime=1795004363274, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329907948366705176, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905755949478607, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329907948366705177, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905755949478607, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=998, endPage=1002, ext={EN=ArticleExt(id=1329905806566338933, articleId=1329905806335652212, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Improved Synthesis of the Anticoagulant Drug Dabigatran Etexilate Mesylate, columnId=1322624454216238014, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Paper, runingTitle=null, highlight=null, articleAbstract=

The synthesis process of dabigatran etexilate mesylate(1) was improved. Using N-(4-cyanophenyl)-glycine(2) and 3-[(3-amino-4-methylaminobenzoyl)(pyridin-2-yl)amino]ethyl propionate(3) as the starting materials,1 was synthesized through amidation, cyclization, aminolysis, reduction, amidation and salinization. The overall yield was approximately 34.5%(based on 3), with a purity of 99.73%. The key step of the improvement lay in the preparation of ethyl 3-[[[2-[[(4-amidinophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino]-propionate benzenesulfonate. This step abandoned the purification by column chromatography and the use of flammable solvent system, and also avoided the use of expensive Pd/C and heavily polluting Fe powder in the catalytic hydrogenation.The improved process features low cost, simple and safe operation, making it suitable for industrial production.

, authors=Wanchun GONG, Jianshu XIE, Guangxin XIA, authorsList=Wanchun GONG, Jianshu XIE, Guangxin XIA, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329905806914466166, articleId=1329905806335652212, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=抗凝血药甲磺酸达比加群酯的合成工艺改进, columnId=1322624454384010176, journalTitle=中国医药工业杂志, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=

该文报道了甲磺酸达比加群酯(1)合成工艺的改进。以N-(4-氰基苯基)甘氨酸(2)和3-[(3-氨基-4-甲胺基苯甲酰基)-(吡啶-2-基)氨基]丙酸乙酯(3)为起始原料,经酰胺化、环合、胺解、还原、酰胺化和成盐反应,得目标产物1。总收率约34.5%(以3计),纯度99.73%。改进的关键步骤在于3-[[[2-[[(4-脒基苯基)氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]-羰基](吡啶-2-基)氨基]丙酸乙酯苯磺酸盐的制备,该步反应摒弃了色谱柱纯化操作和易燃溶剂体系,催化氢化也避免使用价格昂贵的钯炭以及会造成环境污染的铁粉。改进后的工艺成本较低,操作简单安全,适合工业化生产。

, authors=巩万春, 谢建树, 夏广新, authorsList=巩万春, 谢建树, 夏广新, authorCompany=null, correspAuthors=null, authorNote=

巩万春,高级工程师,从事原料药合成工艺的研究。

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=3GDRRUY9ERs1HsOGGENhIg==, magXml=5+ZHeq1wY8XNfNZqYx/HeA==, pdfUrl=null, pdf=NRi3VBbpzYWaLqsI34Dgig==, pdfFileSize=1071441, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=W8KjovbZnlNbdx2usJ+2NA==, mapNumber=null, fund=null)}, authors=[Author(id=1329905807459725692, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905807589749118, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, authorId=1329905807459725692, language=EN, stringName=Wanchun GONG, firstName=Wanchun, middleName=null, lastName=GONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Key Lab. for Innovative Immunotherapy, Central Research Institute of Shanghai Pharmaceuticals Group Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905807702995327, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, authorId=1329905807459725692, language=CN, stringName=巩万春, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203, bio={"content":"

巩万春,高级工程师,从事原料药合成工艺的研究。

"}, bioImg=null, bioContent=

巩万春,高级工程师,从事原料药合成工艺的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905807317119352, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, xref=null, ext=[AuthorCompanyExt(id=1329905807350673785, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, companyId=1329905807317119352, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Key Lab. for Innovative Immunotherapy, Central Research Institute of Shanghai Pharmaceuticals Group Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1329905807367451002, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, companyId=1329905807317119352, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203)])]), Author(id=1329905808072094081, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905808315363715, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, authorId=1329905808072094081, language=EN, stringName=Jianshu XIE, firstName=Jianshu, middleName=null, lastName=XIE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Key Lab. for Innovative Immunotherapy, Central Research Institute of Shanghai Pharmaceuticals Group Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905808399249796, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, authorId=1329905808072094081, language=CN, stringName=谢建树, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905807317119352, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, xref=null, ext=[AuthorCompanyExt(id=1329905807350673785, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, companyId=1329905807317119352, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Key Lab. for Innovative Immunotherapy, Central Research Institute of Shanghai Pharmaceuticals Group Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1329905807367451002, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, companyId=1329905807317119352, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203)])]), Author(id=1329905808533467526, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905808671879560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, authorId=1329905808533467526, language=EN, stringName=Guangxin XIA, firstName=Guangxin, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Key Lab. for Innovative Immunotherapy, Central Research Institute of Shanghai Pharmaceuticals Group Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905808751571337, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, authorId=1329905808533467526, language=CN, stringName=夏广新, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905807317119352, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, xref=null, ext=[AuthorCompanyExt(id=1329905807350673785, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, companyId=1329905807317119352, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Key Lab. for Innovative Immunotherapy, Central Research Institute of Shanghai Pharmaceuticals Group Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1329905807367451002, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, companyId=1329905807317119352, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203)])])], keywords=[Keyword(id=1329905808843846026, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, language=EN, orderNo=1, keyword=anticoagulant drug), Keyword(id=1329905808944509323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, language=EN, orderNo=2, keyword=dabigatran etexilate mesylate), Keyword(id=1329905809028395404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, language=EN, orderNo=3, keyword=synthesis), Keyword(id=1329905809087115661, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, language=EN, orderNo=4, keyword=catalytic hydrogenation), Keyword(id=1329905809187778958, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, language=EN, orderNo=5, keyword=process improvement), Keyword(id=1329905809259082127, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, language=CN, orderNo=1, keyword=抗凝血药), Keyword(id=1329905809334579600, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, language=CN, orderNo=2, keyword=甲磺酸达比加群酯), Keyword(id=1329905809405882769, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, language=CN, orderNo=3, keyword=合成), Keyword(id=1329905809477185939, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, language=CN, orderNo=4, keyword=催化氢化), Keyword(id=1329905809565266324, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, language=CN, orderNo=5, keyword=工艺改进)], refs=[Reference(id=1329905809649152405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=宫 平, 贾 微.新型口服抗凝血药物达比加群酯[J].世界临床药物, 2008, 29(9): 544-547., articleTitle=null, refAbstract=null), Reference(id=1329905809703678358, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=方 干, 郑永勇, 张晓培, 等.达比加群酯合成路线图解[J].中国医药工业杂志, 2011, 42(9): 717-719., articleTitle=null, refAbstract=null), Reference(id=1329905809787564439, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=HAUEL N H, NAR H, PRIEPKE H, et al.Structure-based design of novel potent nonpeptide thromb ininhibitors [J].J Med Chem, 2002, 45(9): 1757-1766., articleTitle=null, refAbstract=null), Reference(id=1329905809850479000, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=邢松松, 王晓蕾, 周付刚, 等.达比加群酯的合成[J].中国医药工业杂志, 2010, 41(5): 321-325., articleTitle=null, refAbstract=null), Reference(id=1329905809905004953, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=程青芳, 王启发, 陆 微, 等.甲磺酸达比加群酯的合成[J].中国新药杂志, 2012, 43(12): 961-964., articleTitle=null, refAbstract=null), Reference(id=1329905809984696730, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=陈 宇, 竺 伟, 梁 俊, 等.达比加群酯的合成[J].中国医药工业杂志, 2013, 44(7): 652-654., articleTitle=null, refAbstract=null), Reference(id=1329905810043416987, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=郭雅俊, 朱雪焱, 黄 雨, 等.达比加群酯的合成[J].合成化学, 2014, 22(2): 262-264., articleTitle=null, refAbstract=null), Reference(id=1329905810102137244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=贝林格尔.英格海姆国际有限公司.制备4-(苯并咪唑基甲基氨基)-苯甲脒及其盐的改良方法: 中国, 101346360A[P].2009-01-14., articleTitle=null, refAbstract=null), Reference(id=1329905810173440413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=李泽标, 严 军, 林燕峰, 等.一种制备达比加群酯的方法:中国, 104031031B [P].2017-01-11., articleTitle=null, refAbstract=null), Reference(id=1329905810240549278, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=朱津津, 樊士勇, 仲伯华, 等.达比加群酯的合成工艺改进[J].中国药物化学杂志, 2012, 22(3): 204-208., articleTitle=null, refAbstract=null), Reference(id=1329905810307658143, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=李立标, 张 瑾, 郑 爱, 等.一种制备达比加群酯的改进方法: 中国, 105348262B [P].2018-09-04., articleTitle=null, refAbstract=null), Reference(id=1329905810366378400, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=巩万春, 黄 建, 谢建树, 等.一种苯磺酸盐、其制备方法及其在制备达比加群酯中的应用:中国, 111253369A [P].2020-06-09., articleTitle=null, refAbstract=null), Reference(id=1329905810441875873, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=刘 雄, 阮张寅, 周国斌, 等.一种达比加群酯中间体的制备方法: 中国, 111440149A [P].2020-07-24., articleTitle=null, refAbstract=null), Reference(id=1329905810508984738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=张传磊, 侯卫波, 王 超,等.镍催化加氢制备T酸的方法研究[J].染料与染色, 2020, 57(2): 17-19., articleTitle=null, refAbstract=null), Reference(id=1329905810576093603, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=工业和信息化部.中华人民共和国工业和信息化部公告2021年第25号[J].再生资源与循环经济, 2021, 14(11): 7., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329905807317119352, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, xref=null, ext=[AuthorCompanyExt(id=1329905807350673785, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, companyId=1329905807317119352, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Key Lab. for Innovative Immunotherapy, Central Research Institute of Shanghai Pharmaceuticals Group Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1329905807367451002, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, companyId=1329905807317119352, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.08.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.08.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2025.08.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2025.08.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1754755200000, fullTextJson=null, articleText=null, reference=null)
收藏切换
抗凝血药甲磺酸达比加群酯的合成工艺改进
巩万春 , 谢建树 , 夏广新
中国医药工业杂志 | 研究论文 2025,56(8): 998-1002
收起
收藏切换
中国医药工业杂志 |研究论文 2025 , 56 (8) : 998 -1002
抗凝血药甲磺酸达比加群酯的合成工艺改进
全屏
[Author(id=1329905807459725692, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905807589749118, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, authorId=1329905807459725692, language=EN, stringName=Wanchun GONG, firstName=Wanchun, middleName=null, lastName=GONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Key Lab. for Innovative Immunotherapy, Central Research Institute of Shanghai Pharmaceuticals Group Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905807702995327, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, authorId=1329905807459725692, language=CN, stringName=巩万春, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203, bio={"content":"

巩万春,高级工程师,从事原料药合成工艺的研究。

"}, bioImg=null, bioContent=

巩万春,高级工程师,从事原料药合成工艺的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905807317119352, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, xref=null, ext=[AuthorCompanyExt(id=1329905807350673785, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, companyId=1329905807317119352, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Key Lab. for Innovative Immunotherapy, Central Research Institute of Shanghai Pharmaceuticals Group Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1329905807367451002, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, companyId=1329905807317119352, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203)])]), Author(id=1329905808072094081, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905808315363715, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, authorId=1329905808072094081, language=EN, stringName=Jianshu XIE, firstName=Jianshu, middleName=null, lastName=XIE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Key Lab. for Innovative Immunotherapy, Central Research Institute of Shanghai Pharmaceuticals Group Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905808399249796, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, authorId=1329905808072094081, language=CN, stringName=谢建树, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905807317119352, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, xref=null, ext=[AuthorCompanyExt(id=1329905807350673785, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, companyId=1329905807317119352, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Key Lab. for Innovative Immunotherapy, Central Research Institute of Shanghai Pharmaceuticals Group Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1329905807367451002, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, companyId=1329905807317119352, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203)])]), Author(id=1329905808533467526, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905808671879560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, authorId=1329905808533467526, language=EN, stringName=Guangxin XIA, firstName=Guangxin, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Key Lab. for Innovative Immunotherapy, Central Research Institute of Shanghai Pharmaceuticals Group Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905808751571337, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, authorId=1329905808533467526, language=CN, stringName=夏广新, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905807317119352, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, xref=null, ext=[AuthorCompanyExt(id=1329905807350673785, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, companyId=1329905807317119352, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Key Lab. for Innovative Immunotherapy, Central Research Institute of Shanghai Pharmaceuticals Group Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1329905807367451002, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905806335652212, companyId=1329905807317119352, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203)])])]
巩万春, 谢建树, 夏广新
作者信息
  • 上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203
作者简介:

巩万春,高级工程师,从事原料药合成工艺的研究。

Improved Synthesis of the Anticoagulant Drug Dabigatran Etexilate Mesylate
Wanchun GONG, Jianshu XIE, Guangxin XIA
Affiliations
  • National Key Lab. for Innovative Immunotherapy, Central Research Institute of Shanghai Pharmaceuticals Group Co., Ltd., Shanghai 201203
出版时间: 2025-08-10 doi: 10.16522/j.cnki.cjph.2025.08.004
文章导航
收藏切换

该文报道了甲磺酸达比加群酯(1)合成工艺的改进。以N-(4-氰基苯基)甘氨酸(2)和3-[(3-氨基-4-甲胺基苯甲酰基)-(吡啶-2-基)氨基]丙酸乙酯(3)为起始原料,经酰胺化、环合、胺解、还原、酰胺化和成盐反应,得目标产物1。总收率约34.5%(以3计),纯度99.73%。改进的关键步骤在于3-[[[2-[[(4-脒基苯基)氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]-羰基](吡啶-2-基)氨基]丙酸乙酯苯磺酸盐的制备,该步反应摒弃了色谱柱纯化操作和易燃溶剂体系,催化氢化也避免使用价格昂贵的钯炭以及会造成环境污染的铁粉。改进后的工艺成本较低,操作简单安全,适合工业化生产。

抗凝血药  /  甲磺酸达比加群酯  /  合成  /  催化氢化  /  工艺改进

The synthesis process of dabigatran etexilate mesylate(1) was improved. Using N-(4-cyanophenyl)-glycine(2) and 3-[(3-amino-4-methylaminobenzoyl)(pyridin-2-yl)amino]ethyl propionate(3) as the starting materials,1 was synthesized through amidation, cyclization, aminolysis, reduction, amidation and salinization. The overall yield was approximately 34.5%(based on 3), with a purity of 99.73%. The key step of the improvement lay in the preparation of ethyl 3-[[[2-[[(4-amidinophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino]-propionate benzenesulfonate. This step abandoned the purification by column chromatography and the use of flammable solvent system, and also avoided the use of expensive Pd/C and heavily polluting Fe powder in the catalytic hydrogenation.The improved process features low cost, simple and safe operation, making it suitable for industrial production.

anticoagulant drug  /  dabigatran etexilate mesylate  /  synthesis  /  catalytic hydrogenation  /  process improvement
巩万春, 谢建树, 夏广新. 抗凝血药甲磺酸达比加群酯的合成工艺改进. 中国医药工业杂志, 2025 , 56 (8) : 998 -1002 . DOI: 10.16522/j.cnki.cjph.2025.08.004
Wanchun GONG, Jianshu XIE, Guangxin XIA. Improved Synthesis of the Anticoagulant Drug Dabigatran Etexilate Mesylate[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (8) : 998 -1002 . DOI: 10.16522/j.cnki.cjph.2025.08.004

参考文献 引证文献
排序方式:
[1]
宫 平, 贾 微.新型口服抗凝血药物达比加群酯[J].世界临床药物, 2008, 29(9): 544-547.
[2]
方 干, 郑永勇, 张晓培, 等.达比加群酯合成路线图解[J].中国医药工业杂志, 2011, 42(9): 717-719.
[3]
HAUEL N H, NAR H, PRIEPKE H, et al.Structure-based design of novel potent nonpeptide thromb ininhibitors [J].J Med Chem, 2002, 45(9): 1757-1766.
[4]
邢松松, 王晓蕾, 周付刚, 等.达比加群酯的合成[J].中国医药工业杂志, 2010, 41(5): 321-325.
[5]
程青芳, 王启发, 陆 微, 等.甲磺酸达比加群酯的合成[J].中国新药杂志, 2012, 43(12): 961-964.
[6]
陈 宇, 竺 伟, 梁 俊, 等.达比加群酯的合成[J].中国医药工业杂志, 2013, 44(7): 652-654.
[7]
郭雅俊, 朱雪焱, 黄 雨, 等.达比加群酯的合成[J].合成化学, 2014, 22(2): 262-264.
[8]
贝林格尔.英格海姆国际有限公司.制备4-(苯并咪唑基甲基氨基)-苯甲脒及其盐的改良方法: 中国, 101346360A[P].2009-01-14.
[9]
李泽标, 严 军, 林燕峰, 等.一种制备达比加群酯的方法:中国, 104031031B [P].2017-01-11.
[10]
朱津津, 樊士勇, 仲伯华, 等.达比加群酯的合成工艺改进[J].中国药物化学杂志, 2012, 22(3): 204-208.
[11]
李立标, 张 瑾, 郑 爱, 等.一种制备达比加群酯的改进方法: 中国, 105348262B [P].2018-09-04.
[12]
巩万春, 黄 建, 谢建树, 等.一种苯磺酸盐、其制备方法及其在制备达比加群酯中的应用:中国, 111253369A [P].2020-06-09.
[13]
刘 雄, 阮张寅, 周国斌, 等.一种达比加群酯中间体的制备方法: 中国, 111440149A [P].2020-07-24.
[14]
张传磊, 侯卫波, 王 超,等.镍催化加氢制备T酸的方法研究[J].染料与染色, 2020, 57(2): 17-19.
[15]
工业和信息化部.中华人民共和国工业和信息化部公告2021年第25号[J].再生资源与循环经济, 2021, 14(11): 7.
2025年第56卷第8期
36
8
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2025.08.004
  • 接收时间:2024-10-18
  • 首发时间:2026-11-18
  • 出版时间:2025-08-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-10-18
基金
作者信息
    上海医药集团股份有限公司中央研究院,创新免疫治疗全国重点实验室,上海 201203
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.08.004
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏